 Glomerulonephritis, Membranous
"Glomerulonephritis, Membranous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Descriptor ID |
D015433
|
| MeSH Number(s) |
C12.777.419.570.363.625 C13.351.968.419.570.363.625 C20.111.535
|
| Concept/Terms |
Glomerulonephritis, Membranous- Glomerulonephritis, Membranous
- Glomerulonephritides, Membranous
- Membranous Glomerulonephritides
- Membranous Glomerulonephritis
- Nephropathy, Membranous
- Membranous Glomerulopathy
- Glomerulopathy, Membranous
- Membranous Nephropathy
- Extramembranous Glomerulopathy
- Glomerulopathy, Extramembranous
- Membranous Glomerulonephropathy
- Glomerulonephropathy, Membranous
Idiopathic Membranous Glomerulonephritis- Idiopathic Membranous Glomerulonephritis
- Glomerulonephritides, Idiopathic Membranous
- Glomerulonephritis, Idiopathic Membranous
- Idiopathic Membranous Glomerulonephritides
- Membranous Glomerulonephritides, Idiopathic
- Membranous Glomerulonephritis, Idiopathic
- Idiopathic Membranous Nephropathy
- Membranous Nephropathy, Idiopathic
- Nephropathy, Idiopathic Membranous
|
Below are MeSH descriptors whose meaning is more general than "Glomerulonephritis, Membranous".
Below are MeSH descriptors whose meaning is more specific than "Glomerulonephritis, Membranous".
This graph shows the total number of publications written about "Glomerulonephritis, Membranous" by people in UAMS Profiles by year, and whether "Glomerulonephritis, Membranous" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2020 | 3 | 0 | 3 | | 2019 | 2 | 0 | 2 | | 2015 | 1 | 0 | 1 | | 2014 | 2 | 0 | 2 | | 2013 | 2 | 0 | 2 | | 2012 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glomerulonephritis, Membranous" by people in Profiles over the past ten years.
-
Sethi S, Casal Moura M, Madden B, Debiec H, Nasr SH, Larsen CP, Gross L, Negron V, Singh RD, Nath KA, Storey AJ, Specks U, Fervenza FC, Ronco P, Caza TN. Proprotein convertase subtilisin/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use. Kidney Int. 2023 08; 104(2):343-352.
-
Caza TN, Storey AJ, Hassen SI, Herzog C, Edmondson RD, Arthur JM, Kenan DJ, Larsen CP. Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry. Kidney Int. 2023 03; 103(3):593-606.
-
Kurien AA, Prema Ks J, Walker PD, Caza TN. Traditional indigenous medicines are an etiologic consideration for NELL1-positive membranous nephropathy. Kidney Int. 2022 12; 102(6):1424-1426.
-
Manral P, Caza TN, Storey AJ, Beck LH, Borza DB. The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy. Front Immunol. 2022; 13:952235.
-
Caza TN, Hassen SI, Kenan DJ, Storey A, Arthur JM, Herzog C, Edmondson RD, Bourne TD, Beck LH, Larsen CP. Transforming Growth Factor Beta Receptor 3 (TGFBR3)-Associated Membranous Nephropathy. Kidney360. 2021 08 26; 2(8):1275-1286.
-
Caza TN, Hassen SI, Kuperman M, Sharma SG, Dvanajscak Z, Arthur J, Edmondson R, Storey A, Herzog C, Kenan DJ, Larsen CP. Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney Int. 2021 07; 100(1):171-181.
-
Caza TN, Hassen SI, Dvanajscak Z, Kuperman M, Edmondson R, Herzog C, Storey A, Arthur J, Cossey LN, Sharma SG, Kenan DJ, Larsen CP. NELL1 is a target antigen in malignancy-associated membranous nephropathy. Kidney Int. 2021 04; 99(4):967-976.
-
Caza TN, Hassen SI, Larsen CP. Renal Manifestations of Common Variable Immunodeficiency. Kidney360. 2020 06 25; 1(6):491-500.
-
Larsen CP, Sharma SG, Caza TN, Kenan DJ, Storey AJ, Edmondson RD, Herzog C, Arthur JM. Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa deposits. Kidney Int. 2020 03; 97(3):602-608.
-
Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, J?ni P, Cattran DC. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. N Engl J Med. 2019 07 04; 381(1):36-46.
-
Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). Nephron. 2015; 130(3):159-68.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|